Israel Englander Lumos Pharma, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 37,018 shares of LUMO stock, worth $145,480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,018
Previous 37,579
1.49%
Holding current value
$145,480
Previous $105,000
19.05%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding LUMO
# of Institutions
41Shares Held
2.19MCall Options Held
0Put Options Held
0-
Wells Fargo & Company San Francisco, CA415KShares$1.63 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY407KShares$1.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA244KShares$959,2420.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny216KShares$848,1490.0% of portfolio
-
Acuitas Investments, LLC141KShares$555,8390.19% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $33M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...